SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer. The company uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors. Its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development to treat or prevent severe influenza. The company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. The company was founded in 2014 and is based in Sioux Falls, South Dakota.
$25.29M
Dr. Eddie Joe Sullivan Ph.D.
139.00
Sioux Falls, SD
Feb 09, 2021
-0.44
$-6.16
0.71
0.82
-444.09%
-1.56
-0.00
2.26
7.19
0.74
-80.41%
-107.74%
Similar stocks (11)
Third Harmonic Bio, Inc.
THRD
Anebulo Pharmaceuticals, Inc.
ANEB
Unicycive Therapeutics, Inc.
UNCY
Monopar Therapeutics Inc.
MNPR
Cadrenal Therapeutics, Inc.
CVKD
Cardio Diagnostics Holdings, Inc.
CDIO
Fresh Tracks Therapeutics, Inc.
FRTX
Processa Pharmaceuticals, Inc.
PCSA
Quoin Pharmaceuticals, Ltd.
QNRX
PaxMedica, Inc.
PXMD
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.00465%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (11)
Third Harmonic Bio, Inc.
THRD
Anebulo Pharmaceuticals, Inc.
ANEB
Unicycive Therapeutics, Inc.
UNCY
Monopar Therapeutics Inc.
MNPR
Cadrenal Therapeutics, Inc.
CVKD
Cardio Diagnostics Holdings, Inc.
CDIO
Fresh Tracks Therapeutics, Inc.
FRTX
Processa Pharmaceuticals, Inc.
PCSA
Quoin Pharmaceuticals, Ltd.
QNRX
PaxMedica, Inc.
PXMD
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.00465%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%